Works matching AU Hong, Ruoxi

Results: 44

53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells.

Published in:

2016

By:

Ruoxi Hong;
Fei Ma;
Weimin Zhang;
Xiying Yu;
Qing Li;
Yang Luo;
Changjun Zhu;
Wei Jiang;
Binghe Xu;
Hong, Ruoxi;
Ma, Fei;
Zhang, Weimin;
Yu, Xiying;
Li, Qing;
Luo, Yang;
Zhu, Changjun;
Jiang, Wei;
Xu, Binghe

Publication type:

journal article

Scalp metastasis from gastric cancer: A case report and literature review.

Published in:

Oncology Letters, 2015, v. 9, n. 2, p. 641, doi. 10.3892/ol.2014.2708

By:

CHUNXIA DU;
RUOXI HONG;
YUEHUA LIU;
JINWAN WANG;
HONGGANG ZHANG;
XIAODUO YU

Publication type:

Article

Distribution characteristics of immune infiltration and lymphovascular invasion in patients with breast cancer skin recurrence.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03783-6

By:

Zhou, Danyang;
Li, Mei;
Wu, Wei;
Wu, Ying;
Nong, Qiaohong;
Wang, Shusen;
Hong, Ruoxi

Publication type:

Article

Combined Wee1 and EGFR inhibition reveals synergistic antitumor effect in esophageal squamous cell carcinoma.

Published in:

Carcinogenesis, 2023, v. 44, n. 6, p. 451, doi. 10.1093/carcin/bgad038

By:

Chen, Dongshao;
Hong, Ruoxi;
Cao, Youjun;
Wu, Qingnan;
Wang, Yan;
Chen, Jie;
Li, Jinting;
Zhang, Weimin;
Zhan, Qimin

Publication type:

Article

The prognostic significance of skin involvement in breast cancer patients with chest wall recurrence.

Published in:

Annals of Medicine, 2023, v. 55, n. 1, p. 1, doi. 10.1080/07853890.2023.2232299

By:

Zhou, Danyang;
Li, Mei;
Xu, Fei;
Zheng, Qiufan;
Lu, Qianyi;
Hong, Ruoxi;
Wang, Shusen

Publication type:

Article

Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population.

Published in:

Annals of Medicine, 2021, v. 53, n. 1, p. 1358, doi. 10.1080/07853890.2021.1966086

By:

Wang, Liye;
Zhai, Qinglian;
Lu, Qianyi;
Lee, Kaping;
Zheng, Qiufan;
Hong, Ruoxi;
Wang, Shusen

Publication type:

Article

Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population.

Published in:

Annals of Medicine, 2021, v. 53, n. 1, p. 1358, doi. 10.1080/07853890.2021.1966086

By:

Liye Wang;
Qinglian Zhai;
Qianyi Lu;
Kaping Lee;
Qiufan Zheng;
Ruoxi Hong;
Shusen Wang

Publication type:

Article

Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer Registries.

Published in:

PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0128345

By:

Zhu, Wenjie;
Perez, Edith A.;
Hong, Ruoxi;
Li, Qing;
Xu, Binghe

Publication type:

Article

Erratum to: 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells.

Published in:

2016

By:

Hong, Ruoxi;
Ma, Fei;
Zhang, Weimin;
Yu, Xiying;
Li, Qing;
Luo, Yang;
Zhu, Changjun;
Xu, Binghe;
Jiang, Wei

Publication type:

journal article

The Effects of Ganglioside-Monosialic Acid in Taxane-Induced Peripheral Neurotoxicity in Patients with Breast Cancer: A Randomized Trial.

Published in:

2020

By:

Su, Yanhong;
Huang, Jiajia;
Wang, Shusen;
Unger, Joseph M;
Arias-Fuenzalida, Jonathan;
Shi, Yanxia;
Li, Jibin;
Gao, Yongxiang;
Shi, Wei;
Wang, Xinyue;
Peng, Roujun;
Xu, Fei;
An, Xin;
Xue, Cong;
Xia, Wen;
Hong, Ruoxi;
Zhong, Yongyi;
Lin, Ying;
Huang, Heng;
Zhang, Anqin

Publication type:

journal article

Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus.

Published in:

Drug Design, Development & Therapy, 2021, v. 15, p. 3463, doi. 10.2147/DDDT.S314723

By:

Duan, Fangfang;
Song, Chenge;
Ma, Yuyu;
Jiang, Kuikui;
Xu, Fei;
Bi, Xiwen;
Huang, Jiajia;
Hong, Ruoxi;
Huang, Zhangzan;
Lu, Qianyi;
Yuan, Zhongyu;
Wang, Shusen;
Xia, Wen

Publication type:

Article

Genetic analysis of oligo-recurrence breast cancer: correlation with clinical outcomes.

Published in:

BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10833-2

By:

Jiang, Kuikui;
Zhou, Danyang;
Xu, Fei;
Xia, Wen;
Zheng, Qiufan;
Lu, Qianyi;
Luo, Rongzhen;
Hong, Ruoxi;
Wang, Shusen

Publication type:

Article

Pyrotinib and trastuzumab plus palbociclib and fulvestrant in HR+/HER2+ breast cancer patients with brain metastasis.

Published in:

NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00646-2

By:

Chen, Dongshao;
Xu, Fei;
Lu, Yongkui;
Xia, Wen;
Du, Caiwen;
Xiong, Dun;
Song, Dong;
Shi, Yanxia;
Yuan, Zhongyu;
Zheng, Qiufan;
Jiang, Kuikui;
An, Xin;
Xue, Cong;
Huang, Jiajia;
Bi, Xiwen;
Chen, Meiting;
Zhang, Jingmin;
Wang, Shusen;
Hong, Ruoxi

Publication type:

Article

The prognostic value and immune microenvironment association of AR in HER2+ nonmetastatic breast cancer.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00527-0

By:

Zhou, Danyang;
Li, Mei;
Yasin, Mohamed Hussein;
Lu, Qianyi;
Fu, Jia;
Jiang, Kuikui;
Hong, Ruoxi;
Wang, Shusen;
Xu, Fei

Publication type:

Article

BRAF V600E Mutation in Triple-Negative Breast Cancer: A Case Report and Literature Review.

Published in:

Oncology Research & Treatment, 2022, v. 45, n. 1/2, p. 54, doi. 10.1159/000520453

By:

Wang, Liye;
Lu, Qianyi;
Jiang, Kuikui;
Hong, Ruoxi;
Wang, Shusen;
Xu, Fei

Publication type:

Article

BRAF V600E Mutation in Triple-Negative Breast Cancer: A Case Report and Literature Review.

Published in:

Oncology Research & Treatment, 2022, v. 45, n. 1/2, p. 54, doi. 10.1159/000520453

By:

Wang, Liye;
Lu, Qianyi;
Jiang, Kuikui;
Hong, Ruoxi;
Wang, Shusen;
Xu, Fei

Publication type:

Article

Leptomeningeal metastasis from solid tumors: a single center experience in Chinese patients.

Published in:

Journal of Neuro-Oncology, 2013, v. 115, n. 2, p. 285, doi. 10.1007/s11060-013-1228-x

By:

Du, Chunxia;
Hong, Ruoxi;
Shi, Yuankai;
Yu, Xiaoduo;
Wang, Jinwan

Publication type:

Article

Identification and characterization of critical genes associated with tamoxifen resistance in breast cancer.

Published in:

PeerJ, 2020, p. 1, doi. 10.7717/peerj.10468

By:

Kai Zhang;
Kuikui Jiang;
Ruoxi Hong;
Fei Xu;
Wen Xia;
Ge Qin;
Kaping Lee;
Qiufan Zheng;
Qianyi Lu;
Qinglian Zhai;
Shusen Wang

Publication type:

Article

Administration of Lapatinib with Food Increases Its Plasma Concentration in Chinese Patients with Metastatic Breast Cancer: A Prospective Phase II Study.

Published in:

Oncologist, 2020, v. 25, n. 9, p. e1286, doi. 10.1634/theoncologist.2020-0044

By:

Xu, Fei;
Lee, Kaping;
Xia, Wen;
Liao, Hai;
Lu, Qianyi;
Zhang, Jingmin;
Yuan, Huimin;
Zhang, Kai;
Zheng, Qiufan;
Qin, Ge;
Zhai, Qinglian;
Hong, Ruoxi;
Jiang, Kuikui;
Li, Yuan;
Wang, Shusen

Publication type:

Article

Construction of immune score and its prognostic value in invasive lobular carcinoma of the breast using computational pathology analysis.

Published in:

Cancer Medicine, 2024, v. 13, n. 1, p. 1, doi. 10.1002/cam4.6896

By:

Liye Wang;
Peng Sun;
Fei Xu;
Qiufan Zheng;
Kuikui Jiang;
Ruoxi Hong;
Shusen Wang

Publication type:

Article

What is the appropriate genetic testing criteria for breast cancer in the Chinese population?—Analysis of genetic and clinical features from a single cancer center database.

Published in:

Cancer Medicine, 2023, v. 12, n. 12, p. 13019, doi. 10.1002/cam4.5976

By:

Ni, Mengqian;
Wang, Fang;
Yang, Anli;
Shao, Qiong;
Xue, Cong;
Xia, Wen;
Xu, Fei;
Lin, Xi;
Huang, Jiajia;
Bi, Xiwen;
Hong, Ruoxi;
Chen, Meiting;
Zheng, Qiufan;
Jiang, Kuikui;
Xie, Xinhua;
Tang, Jun;
Wang, Xi;
Yuan, Zhongyu;
Wang, Shusen;
Shi, Yanxia

Publication type:

Article

Harnessing the FGFR2/NF2/YAP signaling-dependent necroptosis to develop an FGFR2/IL-8 dual blockade therapeutic strategy.

Published in:

Nature Communications, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41467-025-59318-9

By:

Chen, Dongshao;
Zhao, Zitong;
Hong, Ruoxi;
Yang, Di;
Gong, Ying;
Wu, Qingnan;
Wang, Yan;
Cao, Yiren;
Chen, Jie;
Tai, Yidi;
Liu, Haoyu;
Li, Jinting;
Fan, Jiawen;
Zhang, Weimin;
Song, Yongmei;
Zhan, Qimin

Publication type:

Article

Clinical value of circulating <em>ESR1</em> mutations for patients with metastatic breast cancer: a meta-analysis.

Published in:

Cancer Management & Research, 2018, v. 10, p. 2573, doi. 10.2147/CMAR.S173193

By:

Zhang, Kai;
Hong, Ruoxi;
Xu, Fei;
Xia, Wen;
Kaping, Lee;
Qin, Ge;
Zheng, Qiufan;
Lu, Qianyi;
Shi, Yan Xia;
Yuan, Zhong yu;
Wang, Shusen

Publication type:

Article

The prognostic significance of circulating tumor cell enumeration and HER2 expression by a novel automated microfluidic system in metastatic breast cancer.

Published in:

BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12818-1

By:

Wang, Liye;
Hong, Ruoxi;
Shi, Simei;
Wang, Shusen;
Chen, Yong;
Han, Chao;
Li, Mei;
Ye, Feng

Publication type:

Article

Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer.

Published in:

Breast Cancer Research & Treatment, 2019, v. 173, n. 3, p. 619, doi. 10.1007/s10549-018-4997-2

By:

Xue, Cong;
Wei, Wenwen;
Sun, Peng;
Zheng, Wei;
Diao, Xiaoju;
Xu, Fei;
Huang, Jiajia;
An, Xin;
Xia, Wen;
Hong, Ruoxi;
Jiang, Kuikui;
Huang, Riqing;
Yuan, Zhongyu;
Wang, Shusen;
Li, Anhua;
Zou, Ruhai;
Shi, Yanxia

Publication type:

Article

Prognostic value of endocrine treatment-related symptoms in patients with breast cancer: a meta-analysis.

Published in:

Breast Cancer Research & Treatment, 2016, v. 160, n. 2, p. 197, doi. 10.1007/s10549-016-3995-5

By:

Zheng, Qiufan;
Xia, Wen;
Lu, Qianyi;
Hong, Ruoxi;
Qin, Ge;
Xu, Fei;
Qin, Tao;
Shi, Yanxia;
Yuan, Zhongyu;
Wang, Shusen

Publication type:

Article

Current Situation of Diagnosis and Treatment of HER2-Positive Metastatic Breast Cancer Patients in China: A Nationwide Cross-Sectional Survey of Doctors.

Published in:

Journal of Personalized Medicine, 2023, v. 13, n. 2, p. 365, doi. 10.3390/jpm13020365

By:

Jiang, Kuikui;
Zhou, Danyang;
Hong, Ruoxi;
Lu, Qianyi;
Xu, Fei;
Xia, Wen;
Zheng, Qiufan;
Wang, Shusen

Publication type:

Article

Analysis of the activity and safety of weekly low‐dose bevacizumab‐based regimens in heavily pretreated patients with metastatic breast cancer.

Published in:

Thoracic Cancer, 2018, v. 9, n. 5, p. 613, doi. 10.1111/1759-7714.12627

By:

Zhai, Xiaoyu;
Hong, Ruoxi;
Fan, Ying;
Yuan, Peng;
Wang, Jiayu;
Sang, Die;
Chen, Junlin;
Zhao, Chunying;
Ou, Kaiping;
Ma, Fei;
Xu, Binghe

Publication type:

Article

Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities.

Published in:

PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0138908

By:

Hong, Ruoxi;
Dai, Zhen;
Zhu, Wenjie;
Xu, Binghe

Publication type:

Article

PFKP is transcriptionally repressed by BRCA1/ZBRK1 and predicts prognosis in breast cancer.

Published in:

PLoS ONE, 2020, v. 15, n. 5, p. 1, doi. 10.1371/journal.pone.0233750

By:

Yeerken, Danna;
Hong, Ruoxi;
Wang, Yan;
Gong, Ying;
Liu, Rui;
Yang, Di;
Li, Jinting;
Fan, Jiawen;
Chen, Jie;
Zhang, Weimin;
Zhan, Qimin

Publication type:

Article

Tumor stromal type is associated with stromal PD-L1 expression and predicts outcomes in breast cancer.

Published in:

PLoS ONE, 2019, v. 14, n. 10, p. 1, doi. 10.1371/journal.pone.0223325

By:

Zhai, Qinglian;
Fan, Jiawen;
Lin, Qiulian;
Liu, Xia;
Li, Jinting;
Hong, Ruoxi;
Wang, Shusen

Publication type:

Article

The chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironment.

Published in:

Molecular Cancer, 2018, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12943-018-0871-4

By:

Zhang, Weimin;
Hong, Ruoxi;
Li, Lin;
Wang, Yan;
Du, Peina;
Ou, Yunwei;
Zhao, Zitong;
Liu, Xuefeng;
Xiao, Wenchang;
Dong, Dezuo;
Wu, Qingnan;
Chen, Jie;
Song, Yongmei;
Zhan, Qimin

Publication type:

Article

Breast cancer: an up‐to‐date review and future perspectives.

Published in:

Cancer Communications, 2022, v. 42, n. 10, p. 913, doi. 10.1002/cac2.12358

By:

Hong, Ruoxi;
Xu, Binghe

Publication type:

Article

Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2‐positive breast cancer: An open‐label, dose‐escalation, phase I study.

Published in:

Cancer Communications, 2021, v. 41, n. 2, p. 171, doi. 10.1002/cac2.12135

By:

Hong, Ruoxi;
Xia, Wen;
Wang, Liye;
Lee, Kaping;
Lu, Qianyi;
Jiang, Kuikui;
Li, Shengfeng;
Yu, Jinquan;
Wei, Jin;
Tang, Weijia;
Zhou, Danyang;
An, Xin;
Huang, Jiajia;
Xue, Cong;
Bi, Xiwen;
Shi, Yanxia;
Yuan, Zhongyu;
Xu, Fei;
Wang, Shusen

Publication type:

Article

Cover Image: Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real‐world data analyses and experience of one center.

Published in:

Cancer Communications, 2020, v. 40, n. 5, p. i, doi. 10.1002/cac2.12037

By:

Lu, Qianyi;
Lee, Kaping;
Xu, Fei;
Xia, Wen;
Zheng, Qiufan;
Hong, Ruoxi;
Jiang, Kuikui;
Zhai, Qinglian;
Li, Yuan;
Shi, Yanxia;
Yuan, Zhongyu;
Wang, Shusen

Publication type:

Article

Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real‐world data analyses and experience of one center.

Published in:

Cancer Communications, 2020, v. 40, n. 5, p. 222, doi. 10.1002/cac2.12029

By:

Lu, Qianyi;
Lee, Kaping;
Xu, Fei;
Xia, Wen;
Zheng, Qiufan;
Hong, Ruoxi;
Jiang, Kuikui;
Zhai, Qinglian;
Li, Yuan;
Shi, Yanxia;
Yuan, Zhongyu;
Wang, Shusen

Publication type:

Article

CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4.

Published in:

2021

By:

Lee, Kaping;
Zheng, Qiufan;
Lu, Qianyi;
Xu, Fei;
Qin, Ge;
Zhai, Qinglian;
Hong, Ruoxi;
Chen, Miao;
Deng, Wuguo;
Wang, Shusen

Publication type:

Letter

Distribution Characteristics and Prognostic Value of Immune Infiltration in Oligometastatic Breast Cancer.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.747012

By:

Zhou, Danyang;
Jiang, Kuikui;
Hong, Ruoxi;
Lu, Qianyi;
Xia, Wen;
Li, Mei;
Zheng, Chengyou;
Zheng, Qiufan;
Xu, Fei;
Wang, Shusen

Publication type:

Article

Multi-omics portrait of ductal carcinoma in situ in young women.

Published in:

Breast Cancer Research & Treatment, 2024, v. 206, n. 1, p. 105, doi. 10.1007/s10549-024-07254-5

By:

Hong, Ruoxi;
Cao, Boyang;
Chen, Dongshao;
Wu, Wei;
Luo, Tian;
Lv, Dian;
Zhang, Weimin;
Wang, Shusen;
Shao, Kang

Publication type:

Article

Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study.

Published in:

Breast Cancer Research & Treatment, 2022, v. 196, n. 3, p. 613, doi. 10.1007/s10549-022-06746-6

By:

Zheng, Qiufan;
Luo, Hanjia;
Xia, Wen;
Lu, Qianyi;
Jiang, Kuikui;
Hong, Ruoxi;
Xu, Fei;
Wang, Shusen

Publication type:

Article

Miller–Payne Grading and 70-Gene Signature Are Associated With Prognosis of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer After Neoadjuvant Chemotherapy.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.735670

By:

Wang, Liye;
Luo, Rongzhen;
Lu, Qianyi;
Jiang, Kuikui;
Hong, Ruoxi;
Lee, Kaping;
Zhang, Ping;
Zhou, Danyang;
Wang, Shusen;
Xu, Fei

Publication type:

Article

Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study.

Published in:

Cancer Research & Treatment, 2024, v. 56, n. 2, p. 513, doi. 10.4143/crt.2023.786

By:

Jiang, Kuikui;
Hong, Ruoxi;
Xia, Wen;
Lu, Qianyi;
Li, Liang;
Huang, Jianhao;
Shi, Yanxia;
Yuan, Zhongyu;
Zheng, Qiufan;
An, Xin;
Xue, Cong;
Huang, Jiajia;
Bi, Xiwen;
Chen, Meiting;
Zhang, Jingmin;
Xu, Fei;
Wang, Shusen

Publication type:

Article

The metabolic genomic atlas reveals potential drivers and clinically relevant insights into the etiology of esophageal squamous cell carcinoma.

Published in:

Theranostics, 2022, v. 12, n. 14, p. 6160, doi. 10.7150/thno.70814

By:

Xuesong Liu;
Ruoxi Hong;
Peina Du;
Di Yang;
Meibo He;
Qingnan Wu;
Lin Li;
Yan Wang;
Jie Chen;
Qingjie Min;
Jinting Li;
Weimin Zhang;
Qimin Zhan

Publication type:

Article

Preventing BRCA1/ZBRK1 repressor complex binding to the GOT2 promoter results in accelerated aspartate biosynthesis and promotion of cell proliferation.

Published in:

Molecular Oncology, 2019, v. 13, n. 4, p. 959, doi. 10.1002/1878-0261.12466

By:

Hong, Ruoxi;
Zhang, Weimin;
Xia, Xi;
Zhang, Kai;
Wang, Yan;
Wu, Mengjiao;
Fan, Jiawen;
Li, Jinting;
Xia, Wen;
Xu, Fei;
Chen, Jie;
Wang, Shusen;
Zhan, Qimin

Publication type:

Article